Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 2 Observational 1

Sponsor

Conditions

Brain Neoplasms 8 Cognitive Dysfunction 4 Radiation Injuries 3 Multiple Myeloma 2 Lymphoma 2 Glioma 2 Triple Negative Breast Neoplasms 1 Stroke 1 Parkinson Disease 1 Neoplasms 1 Medulloblastoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Localized, Operable Non-small Cell Lung Cancer 1 Liver Neoplasms 1 Liver Diseases 1 Infratentorial Neoplasms 1 Glioblastoma 1 Fibrosis 1 Fatigue 1 Epilepsy 1 Colorectal Neoplasms 1 Cancer Related Cognitive Difficulties 1 Breast Neoplasms 1 Brain Injuries, Traumatic 1 Astrocytoma 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4 Palliative Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Neuropsychological Tests × Clear all

NCT02320136 2023-12-01

HFO

University of Zurich

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡